PharmiWeb2h
Dr. Vitenas Provides Insight Into Emerging 'Yoga' or 'Ballerina' Breast Augmentation Trend
Dr. Paul Vitenas Unveils 'Yoga Boobs' Trend for Natural, Athletic Breast Augmentation Using Cutting-Edge TechniquesHOUSTON, TX / ACCESSWIRE / September 20, 2024 / Dr. Paul Vitenas, a board-certified ...
PharmiWeb6h
ZetrOZ Systems Provides Targeted Treatment for Common Sports Injuries
The sam® wearable ultrasound biotechnology is purpose-built to treat the most common athletic injuries, accelerating soft tissue healing and reducing the need for surgery or pain medication.TRUMBULL, ...
PharmiWeb7h
DISCOVER FH Collaboration With Family Heart Foundation, UT Southwestern, and Partners
LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September 20, 2024 / GENinCode Plc (AIM:GENI), the genetics ...
PharmiWeb8h
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care ...
PharmiWeb11h
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to ...
PharmiWeb20h
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl ...